ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, announced that Dhiraj Carumbaya has joined the company as Senior Vice President and General Manager of the company's TeraRecon business.
Dhiraj brings over two decades of domain and industry experience in Medical...
New leaders bring deep industry expertise from former roles at Kyruus Health, Health Catalyst, Glytec, HubSpot, and Veeva
Manifold, an AI-powered clinical research platform, announced the expansion of its leadership team with veterans of the technology and healthcare industries. Following its $15 million Series A fundraising round, the expanded team will accelerate...
New Clinically™Platform Combines Claims Adjudication, Clinical Review and Proprietary Population Health Engine into One Integrated Platform
EmpiRx Health, the leading clinically-driven PBM company, launched a powerful new technology platform designed to strengthen and expand the company's customer-first pharmacy care that puts pharmacists at the center of the PBM service model. Called...
Lambda, the GPU cloud company founded by AI engineers and powered by NVIDIA GPUs, announced that Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, has selected Lambda Cloud to provide NVIDIA H100 Tensor Core GPUs to accelerate training and inference for its...
Springbok Analytics, a life sciences muscle analytics company, announced that it has been recognized by Fast Company on its 2024 World Changing Ideas Awards list for its full body MRI muscle health analysis. Named an honorable mention in the Health Services category, Springbok is building a new standard in...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to its discovery portfolio through its collaboration with BenevolentAI.
Novel target for Heart Failure was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated by AstraZeneca
...
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced the completion of BioHive-2, Recursion’s new NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs interconnected by NVIDIA Quantum-2 InfiniBand networking. This NVIDIA-powered AI supercomputer results in four times...
Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology and closing the gap between care and research, announced a collaboration with the Association of Cancer Care Centers (ACCC), a powerful network of more than 40,000 multidisciplinary practitioners from cancer care...
Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, announced the expansion of its artificial intelligence (AI) capabilities in the Beacon platform. Beacon is a modern content activation and Healthcare Professional (HCP) engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market...
Dyno Therapeutics announced a collaboration with NVIDIA to leverage Dyno’s field-leading artificial intelligence (AI) and in vivo experimentation capabilities, along with the built-to-scale NVIDIA BioNeMo AI-powered drug design platform, to help advance biological sequence design.
Everything life does is controlled by biological sequences: DNA, RNA, and proteins. The capacity to design...
